NPS Pharmaceuticals Inc (NPSP)

45.97
0.01 0.02
Prev Close 45.96
Open 45.96
Day Low/High 45.95 / 45.99
52 Wk Low/High 22.11 / 46.01
Volume 9.49M
Avg Volume 4.75M
Exchange
Shares Outstanding 108.58M
Market Cap 4.99B
EPS -0.08
Div & Yield N.A. (N.A)

Latest News

Valeant Boosts Offer for Salix to $15.8 Billion, Endo Drops Bid

Valeant Boosts Offer for Salix to $15.8 Billion, Endo Drops Bid

Valeant comes out on top, following a competing bid from Endo International for the gastrointestinal drugmaker Salix.

'Mad Money' Lightning Round: Ambarella Is Like Putting a Gun to Your Head

'Mad Money' Lightning Round: Ambarella Is Like Putting a Gun to Your Head

Cramer says take the money and run on NPS Pharmaceuticals, stay away from VMware and he missed the boat on OvaScience.

Jim Cramer's 'Mad Money' Recap: Zombie Stocks That Will Rise From the Dead

Jim Cramer's 'Mad Money' Recap: Zombie Stocks That Will Rise From the Dead

Many of the stocks hit hard Wednesday will rise again soon enough, Cramer says.

NPS PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of NPS Pharmaceuticals, Inc. (NPSP) Over The Proposed Sale Of The Company To Shire PLC

NPS PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of NPS Pharmaceuticals, Inc. (NPSP) Over The Proposed Sale Of The Company To Shire PLC

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of NPS Pharmaceuticals, Inc.

FDA Approves Natpara® (parathyroid Hormone) For Injection As An Adjunct To Calcium And Vitamin D To Control Hypocalcemia In Patients With Hypoparathyroidism

FDA Approves Natpara® (parathyroid Hormone) For Injection As An Adjunct To Calcium And Vitamin D To Control Hypocalcemia In Patients With Hypoparathyroidism

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the U.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of NPS Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of NPS Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of NPS...

NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of NPS Pharmaceuticals, Inc. Over The Proposed Sale Of The Company To Shire Plc - NPSP

NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of NPS Pharmaceuticals, Inc. Over The Proposed Sale Of The Company To Shire Plc - NPSP

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of NPS Pharmaceuticals, Inc.

NPSP INVESTOR ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of NPS Pharmaceuticals Inc. In Connection With The Fairness Of The Sale Of The Company To Shire Plc

NPSP INVESTOR ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of NPS Pharmaceuticals Inc. In Connection With The Fairness Of The Sale Of The Company To Shire Plc

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of NPS Pharmaceuticals Inc.

Jim Cramer's Top Stock Picks: ISIS CELG NPSP AA ACOR

Jim Cramer's Top Stock Picks: ISIS CELG NPSP AA ACOR

Cramer remains a big fan of Alcoa and thinks Acorda Therapeutics is exactly what investors should be looking for in a growth stock.

Jim Cramer's 'Mad Money' Recap: Blame Tech, Oil and Retail for Today's Losses

Jim Cramer's 'Mad Money' Recap: Blame Tech, Oil and Retail for Today's Losses

The restaurants and the biotechs tried their best to save us but it just wasn't enough, Cramer says.

NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of NPS Pharmaceuticals, Inc. Over The Proposed Sale Of The Company To Shire Plc

NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of NPS Pharmaceuticals, Inc. Over The Proposed Sale Of The Company To Shire Plc

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of NPS Pharmaceuticals, Inc.

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of NPS Pharmaceuticals, Inc. Stockholders

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of NPS Pharmaceuticals, Inc. Stockholders

Kirby McInerney LLP is investigating potential claims against NPS Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of NPS Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of NPS Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of NPS...

Shire's Takeover of NPS Pharmaceuticals: What Wall Street's Saying

Shire's Takeover of NPS Pharmaceuticals: What Wall Street's Saying

Here's what analysts were saying about Shire's takeover of NPS Pharmaceuticals.

Stocks Sink as Wall Street 'Fixates' on Stabilization in Oil Prices

Stocks Sink as Wall Street 'Fixates' on Stabilization in Oil Prices

Oil continues to pressure stock markets on Monday following a price warning from Goldman Sachs analysts.

Jim Cramer Explains Why Shire's Purchase of NPS Pharmaceuticals (NPSP) is Important

Jim Cramer Explains Why Shire's Purchase of NPS Pharmaceuticals (NPSP) is Important

TheStreet's Jim Cramer explains why he likes Shire's (SHPG) deal to buy NPS Pharmaceuticals (NPSP) for $5.2 billion in an all-cash transaction.

3 Stocks Moving The Health Care Sector Upward

3 Stocks Moving The Health Care Sector Upward

TheStreet highlights 3 stocks pushing the health care sector higher today.

NPS PHARMACEUTICALS INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Shire PLC

NPS PHARMACEUTICALS INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Shire PLC

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of NPS...